Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
281
mentions
- X 131
- News 76
- Facebook 42
- Blogs 23
- +3 more
Bernard Zinman
PubHawk tracks social media discussions for 5 articles by authors named Bernard Zinman.
Mentions
626
Peak: 21 in Aug 2020
across 5 tracked articles
Extended reach
1,655,623
potential audience
Total likes
4,295
Video views
143,765
Mentions per month
Sep 2015 – Nov 2025Where it's discussed
-
News256 articles
-
X / Twitter189 posts
-
Facebook110 posts
-
Blogs50 articles
-
YouTube14 videos
-
Bluesky5 posts
-
Reddit2 posts
Tracked by PubHawk
Most discussed articles
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
207
mentions
- News 140
- Facebook 46
- Blogs 17
- YouTube 3
- +1 more
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics.
63
mentions
- X 47
- News 11
- YouTube 2
- Blogs 2
- +1 more
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
62
mentions
- News 29
- Facebook 22
- Blogs 8
- YouTube 2
- +1 more
Future cardiometabolic implications of insulin hypersecretion in response to oral glucose: a prospective cohort study.
13
mentions
- X 11
- YouTube 2
From PubMed
All publications
Searching PubMed…